VeriMomsalix nigra bark extract은 임신 중 안전한가요?
No EU Annex II/III restriction or harmonised CLP reproductive classification was found. The CIR safety assessment of willow (Salix alba) bark extracts (used as the cosmetic reference in industry reviews) found no reproductive/developmental toxicity at doses up to 1000 mg/kg bw/day (NOAEL) and concluded willow-derived ingredients are safe in cosmetic use levels (reports list typical leave‑on use up to ~1.1%). However, the EMA herbal monograph notes that salicylates from willow products can cross the placenta and advises avoidance in pregnancy (and contraindication in the third trimester) for medicinal/oral use; this provides a theoretical mechanism of concern for systemic salicylates, though there is no direct evidence that typical topical cosmetic use leads to systemic levels causing reproductive effects. Sources: CIR (willow safety assessment), EMA monograph, EWG entry, PubMed reviews.
Pregnancy-safe products containing salix nigra bark extract
Related ingredients
Frequently asked questions
- salix nigra bark extract은 임신 중 안전한가요?
- No EU Annex II/III restriction or harmonised CLP reproductive classification was found. The CIR safety assessment of willow (Salix alba) bark extracts (used as the cosmetic reference in industry reviews) found no reproductive/developmental toxicity at doses up to 1000 mg/kg bw/day (NOAEL) and concluded willow-derived ingredients are safe in cosmetic use levels (reports list typical leave‑on use up to ~1.1%). However, the EMA herbal monograph notes that salicylates from willow products can cross the placenta and advises avoidance in pregnancy (and contraindication in the third trimester) for medicinal/oral use; this provides a theoretical mechanism of concern for systemic salicylates, though there is no direct evidence that typical topical cosmetic use leads to systemic levels causing reproductive effects. Sources: CIR (willow safety assessment), EMA monograph, EWG entry, PubMed reviews.
- salix nigra bark extract은 모유 수유 중 안전한가요?
- Same rationale as for pregnancy. CIR cosmetic assessment shows no reproductive/developmental hazard for willow bark extracts at tested doses; EMA states salicylates appear in breast milk after systemic (oral) exposure and therefore recommends caution for nursing mothers. For topical cosmetic use there is no direct evidence of harmful exposure via breast milk, but the theoretical transfer of salicylates after systemic absorption motivates a precautionary mechanism flag.
- salix nigra bark extract은 아기 피부에 안전한가요?
- No infant-specific reproductive/toxicology data were located. The parent safety assessment (CIR) did not identify reproductive hazards and did not require infant-specific restrictions; however, infant (0–3 yr) skin has higher permeability and higher surface‑area‑to‑weight, so exposure from topical products is increased (+1 exposure per your rules). There is no direct evidence that topical willow bark extracts at typical cosmetic use concentrations produce systemic salicylate levels in infants, but infants with immature barriers or products applied over large areas would have higher exposure.
- VeriMom은 salix nigra bark extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 salix nigra bark extract을 87/100 (낮은 위험)로 평가합니다.
- 임신 중 salix nigra bark extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.